Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Liver Cirrhosis

  Free Subscription

Articles published in Proc Natl Acad Sci U S A

Retrieve available abstracts of 7 articles:
HTML format

Single Articles

    April 2021
  1. NISHIMURA N, De Battista D, McGivern DR, Engle RE, et al
    Chitinase 3-like 1 is a profibrogenic factor overexpressed in the aging liver and in patients with liver cirrhosis.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available

    March 2021
  2. PICCOLO P, Ferriero R, Barbato A, Attanasio S, et al
    Up-regulation of miR-34b/c by JNK and FOXO3 protects from liver fibrosis.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available

    December 2020
  3. YUEH MF, He F, Chen C, Vu C, et al
    Triclosan leads to dysregulation of the metabolic regulator FGF21 exacerbating high fat diet-induced nonalcoholic fatty liver disease.
    Proc Natl Acad Sci U S A. 2020;117:31259-31266.
    PubMed     Abstract available

    November 2020
  4. SCHIERWAGEN R, Dietrich P, Klein S, Uschner FE, et al
    beta-Arrestin2 is increased in liver fibrosis in humans and rodents.
    Proc Natl Acad Sci U S A. 2020;117:27082-27084.

    June 2020
  5. TAN S, Zhao J, Sun Z, Cao S, et al
    Hepatocyte-specific TAK1 deficiency drives RIPK1 kinase-dependent inflammation to promote liver fibrosis and hepatocellular carcinoma.
    Proc Natl Acad Sci U S A. 2020;117:14231-14242.
    PubMed     Abstract available

    May 2020
  6. VERMA M, Chu JN, Salama JAF, Faiz MT, et al
    Development of a long-acting direct-acting antiviral system for hepatitis C virus treatment in swine.
    Proc Natl Acad Sci U S A. 2020 May 18. pii: 2004746117.
    PubMed     Abstract available

    January 2020
  7. WINKLER I, Bitter C, Winkler S, Weichenhan D, et al
    Identification of Ppargamma-modulated miRNA hubs that target the fibrotic tumor microenvironment.
    Proc Natl Acad Sci U S A. 2020;117:454-463.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Liver Cirrhosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.